35.53
前日終値:
$32.54
開ける:
$32.51
24時間の取引高:
290.02K
Relative Volume:
1.88
時価総額:
$445.08M
収益:
-
当期純損益:
$-31.48M
株価収益率:
-34.16
EPS:
-1.04
ネットキャッシュフロー:
$-28.71M
1週間 パフォーマンス:
+16.84%
1か月 パフォーマンス:
+27.48%
6か月 パフォーマンス:
+206.29%
1年 パフォーマンス:
+133.14%
Forte Biosciences Inc Stock (FBRX) Company Profile
名前
Forte Biosciences Inc
セクター
電話
(310) 618-6994
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
FBRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
FBRX
Forte Biosciences Inc
|
35.53 | 407.63M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-25 | 開始されました | Evercore ISI | Outperform |
| 2025-08-18 | 開始されました | Guggenheim | Buy |
| 2025-01-21 | 開始されました | TD Cowen | Buy |
| 2024-04-08 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | アップグレード | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | ダウングレード | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | ダウングレード | Truist | Buy → Hold |
| 2021-05-14 | 開始されました | B. Riley Securities | Buy |
| 2021-03-26 | 開始されました | Citigroup | Buy |
| 2020-08-28 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | 開始されました | Truist | Buy |
すべてを表示
Forte Biosciences Inc (FBRX) 最新ニュース
US Market Recap: What is the earnings history of Jupiter Neurosciences Inc2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
CD122’s double whammy makes for intriguing target - BioWorld MedTech
Is Forte Biosciences Inc. stock oversold or undervaluedJuly 2025 Sector Moves & Real-Time Volume Triggers - bollywoodhelpline.com
Is Forte Biosciences Inc a top pick in the sectorWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Support Test: How does INVE compare to its peersQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
Layoff Watch: Is ERAS stock undervalued right nowMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Value Recap: Does Forte Biosciences Inc have pricing powerPortfolio Gains Report & Daily Growth Stock Tips - baoquankhu1.vn
Trade Recap: Is Forte Biosciences Inc. stock a hidden gemWeekly Gains Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 267.7% in December - MarketBeat
Delaware court rules in D&O dispute - businessinsurance.com
Delaware court expands D&O insurer liability through meaningful linkage ruling - Insurance Business
A activityJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - ulpravda.ru
Will Forte Biosciences Inc. stock outperform international peersLayoff News & High Return Stock Watch Alerts - Улправда
Biopharma Co. Secures D&O Coverage For Shareholder Suit - Law360
Why Forte Biosciences Inc. stock is rated strong buyWeekly Investment Summary & Expert Curated Trade Ideas - Улправда
Biotech Firm Scores Win in D&O Insurance Coverage Dispute - Bloomberg Law News
Will Forte Biosciences Inc. stock reach all time highs in 2025CPI Data & Expert Curated Trade Setups - Улправда
How supply shortages influence HCI stockJuly 2025 Review & Community Driven Trade Alerts - Улправда
What margin trends mean for VNET Group Inc. Depositary Receipt stockTrade Risk Report & Long-Term Safe Investment Ideas - Улправда
What valuation multiples suggest for HAYW stockWeekly Risk Summary & Consistent Growth Equity Picks - Улправда
ulpravda ru > 2026> What insider trading reveals about COLL stockChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru
Will Quad Graphics Inc. stock return to pre crisis levels2025 Key Highlights & Expert Approved Trade Ideas - ulpravda.ru
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
(FBRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Avax Apparels and Ornaments Limited Bounce From 52 Week LowPortfolio Risk Assessment & Interactive Learning for Better Returns - earlytimes.in
Will Sahasra Electronic Solutions Limited Recover After Recent DeclineSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in
What drives Forte Biosciences Inc stock priceMean Reversion Trades & Receive Monthly Expert Trading Blueprints - earlytimes.in
TD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy Recommendation - MSN
Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock - Yahoo Finance
Institutional investors may adopt severe steps after Forte Biosciences, Inc.'s (NASDAQ:FBRX) latest 15% drop adds to a year losses - simplywall.st
Insider Buying: Antony Riley Acquires Shares of Forte Biosciences Inc (FBRX) - GuruFocus
Trading Bots Trigger Alerts on Shri Venkatesh Refineries Limited ActivityHigh Frequency Trading Trends & Fast Profit Trading Ideas - bollywoodhelpline.com
Indo Tech Transformers Limited (INDOTECH) Stock RalliesStock Liquidity Analysis & Discover Stocks Experts Are Watching - bollywoodhelpline.com
Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New MarketRisk-Reward Ratio Analysis & Fast Profit Capital Growth - bollywoodhelpline.com
Forte Biosciences Inc. (FBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Shorts Report: Will Forte Biosciences Inc stock return to pre crisis levelsJuly 2025 Update & Consistent Profit Trade Alerts - moha.gov.vn
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Gaining experience for doing equity researchDividend Yield Trends & Free Fastest Return On Investment - bollywoodhelpline.com
Rate Hike: Is Forte Biosciences Inc stock dividend yield sustainable2025 Pullback Review & Weekly Watchlist of Top Performers - moha.gov.vn
Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Bluefield Daily Telegraph
New Forte Biosciences hire receives options for 75,000 shares - Stock Titan
Gainers Report: Can Cytosorbents Corporation stock deliver sustainable ROEJuly 2025 Patterns & Fast Exit and Entry Trade Guides - moha.gov.vn
Why analysts upgrade Forte Biosciences Inc. stock2025 Top Gainers & Expert Curated Trade Ideas - Улправда
Ester Industries Limited Recovers — But Is It SustainableGap Fill Strategies & Low Risk Capital Growth - Bollywood Helpline
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Dow Update: Why Dune Acquisition Corporation Equity Warrant stock remains on buy listsPortfolio Profit Report & Low Risk Entry Point Guides - Улправда
Forte Biosciences initiated with an Outperform at Evercore ISI - MSN
Forte Biosciences Inc (FBRX) 財務データ
収益
当期純利益
現金流量
EPS
Forte Biosciences Inc (FBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '26 |
Option Exercise |
0.00 |
375 |
0 |
41,895 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Dec 30 '25 |
Buy |
26.33 |
9,680 |
254,833 |
41,520 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Oct 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,974 |
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
大文字化:
|
ボリューム (24 時間):